Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

Majority of Europeans Oppose Use of GMOs, EU Survey Finds

March 19, 2008

By Peter O'Donnell

EU Regulators More Confident Than Europe's Biotech Firms

March 12, 2008

By Peter O'Donnell

Ablynx, Galapagos Announce Big Ambitions for This Year

March 5, 2008

By Peter O'Donnell

Ablynx, Galapagos Announce Big Ambitions for This Year

March 5, 2008

By Peter O'Donnell

EU Industry Backs Database on Life Sciences Projects

Feb. 27, 2008

By Peter O'Donnell

EU Industry Backs Database on Life Sciences Projects

Feb. 27, 2008

By Peter O'Donnell

Europe Only 'Flirting' with Biotech, Farmers Charge

Feb. 20, 2008

By Peter O'Donnell

Europe Only 'Flirting' with Biotech, Farmers Charge

Feb. 20, 2008

By Peter O'Donnell

Ablynx Rejects Antibody Patent Claims from GSK's Domantis

Feb. 13, 2008

By Peter O'Donnell

Ablynx Rejects Antibody Patent Claims from GSK's Domantis

Feb. 13, 2008

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...